Apr. 18, 2019
On the evening of 9th April 2019, ABA Chemicals announced its first quarter report which reveals net profits to be delivered to shareholders of Yuan46.08 – 57.14 million in the first quarter, a 25%-55% increase year on year.
Not long ago, on the 28th February 2018, ABA Chemicals released the company’s 2018 annual report. According to the company, in 2018 ABA Chemicals reported business income of Yuan1.806 billion, which is a 49.50% increase year on year, business profits of Yuan222 million, which is up 186.18% year on year, and net shareholders profits of Yuan161 million, which is a 120% increase year on year.
ABA Chemicals attributes growth in 2018 to the increase in pesticide contract production for overseas markets and the significant growth of pharmaceutical contract production. In the meantime, the synergistic effect among the company’s pharmaceuticals, APIs, intermediates and bio-enzymes has gradually been built up, resulting in significant growth of pharmaceutical contract production.
ABA Chemicals is a high-end contract manufacturer in Chinese pharmaceutical and the pesticide intermediate industry. For many years, the company has maintained strategic cooperations with agrochemical giants such as DuPont, Bayer and FMC, being involved in joint research of pesticides at early stages, while being bound to the sales of products after the releases of subsequent products.
ABA Chemicals also owns four large scale production bases and a number of 1,000-ton automated production lines. The company has established its pharmaceutical contract production facility, ACL, in Malta Europe, which allows for an international contract production arrangement and API market deployment ,as well as for enhancement of its service capacity, in favor of the key pharmaceutical clients of the company.